Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 4
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean cynkier p[au] (11 results)?
Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium.
Beyer K, Leenen R, Venderbos LDF, Helleman J, Denijs F, Bramer W, Vasilyeva V, Briers E, Rivas JG, Chloupkova R, Majek O, Annemans L, Vynckier P, Basu P, Chandran A, van den Bergh R, Collen S, van Poppel H, Roobol MJ, On Behalf Of The Praise-U Consortium. Beyer K, et al. Among authors: vynckier p. J Pers Med. 2024 Jan 11;14(1):84. doi: 10.3390/jpm14010084. J Pers Med. 2024. PMID: 38248785 Free PMC article. Review.
Medical Treatment in Coronary Patients: Is there Still a Gender Gap? Results from European Society of Cardiology EUROASPIRE V Registry.
Vynckier P, Ferrannini G, Rydén L, Tokgözoğlu L, Bruthans J, Kotseva K, Wood D, De Backer T, Gevaert S, De Bacquer D, De Smedt D; EUROASPIRE V Investigators group. Vynckier P, et al. Cardiovasc Drugs Ther. 2021 Aug;35(4):801-808. doi: 10.1007/s10557-020-07095-6. Epub 2020 Oct 17. Cardiovasc Drugs Ther. 2021. PMID: 33068226
Gender differences in risk factor management and pharmacological treatment among CHD patients: Belgian results of the EUROASPIRE IV and EUROASPIRE V surveys.
Vynckier P, De Sutter J, De Pauw M, Vandekerckhove H, De Backer G, Vervaet P, Deweerdt N, Dendale P, Persu A, Janssen A, Chenu P, Kotseva K, Gevaert S, De Bacquer D, De Smedt D; EUROASPIRE V Investigators Group; EUROASPIRE IV. Vynckier P, et al. Acta Cardiol. 2023 Jul;78(5):607-613. doi: 10.1080/00015385.2023.2169439. Epub 2023 Feb 13. Acta Cardiol. 2023. PMID: 36779380
Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys.
Ferrannini G, De Bacquer D, Vynckier P, De Backer G, Gyberg V, Kotseva K, Mellbin L, Norhammar A, Tuomilehto J, Wood D, Rydén L; EUROASPIRE IV & V Investigators. Ferrannini G, et al. Among authors: vynckier p. Cardiovasc Diabetol. 2021 Feb 11;20(1):38. doi: 10.1186/s12933-021-01233-6. Cardiovasc Diabetol. 2021. PMID: 33573665 Free PMC article.